Postmenopausal survivors of breast cancer at risk for osteoporosis: Nutritional intake and body size

Cancer Nursing

Volumn 25, Issue 1, 2002, Pages 50-56

  Lindsey, Ada M ^a   Gross, Gloria ^a   Twiss, Jan ^a   Waltman, Nancy ^a   Ott, Carol ^a   Moore, Timothy E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Calcium and vitamin D; Nutritional status; Osteoporosis risk; Survivors of breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; HORMONE; TAMOXIFEN; TUMS; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BODY SIZE; BONE DENSITY; BONE MINERAL; BREAST CANCER; CALCIUM INTAKE; CANCER SURVIVAL; CLINICAL ARTICLE; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; VITAMIN INTAKE;

EID: 0036155273     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200202000-00010     Document Type: Article

References (63)

1. Estrogen replacement therapy in breast cancer survivors
2. Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy
3. Osteoporosis: A concern for cancer survivors
4. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy
5. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
6. Evidence that increased calcium intake does not prevent early postmenopausal bone loss
7. Chemotherapy induced ovarian failure (CHEMO OV FAIL) is associated with significant bone loss in early stage breast cancer patients
8. Barriers to osteoporosis prevention in perimenopausal and elderly women
9. Epidemiology of osteoporosis and osteoporotic fractures
10. Primary prevention of postmenopausal osteoporosis
11. Bisphosphonates in the treatment of osteoporosis
12. Dose-response relationships for alendronate treatment in osteoporotic elderly women
13. Effect of alendronate on risk of fracture in women with low bone density but with vertebral fractures. Results from the fracture intenention trial
14. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
15. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
16. Treatment with alendronate prevents fractures in women at highest risk
17. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
18. Osteoporosis: Current pharmacologic options for prevention and treatment
19. Prevention of nonvertebral fractures by alendronate: A meta-analysis
20. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial
21. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis
22. Alendronate prevents postmenopausal bone loss in women without osteoporosis
23. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients
24. Does long-term administration of tamoxifen affect bone mineral density?
25. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women
26. Nutritional factors in osteoporosis
27. Exercise and regional bone mineral density in postmenopausal women. A meta-analytic review of randomized trials
28. NIH consensus conference, optimum calcium intake
29. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized trial
30. The effects of weight training on bone density of premenopausal, postmenopausal, and elderly women: A review
31. The effect of exercise training programs on bone mass: A meta-analysis of published controlled trials in pre- and postmenopausal women
32. Prevention and treatment of osteoporosis in breast cancer survivors
33. Bone mineral density in postmenopausal breast cancer survivors
34. Calcium supplementation with and without hormone replacement therapy to prevent post-menopausal bone loss
35. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women
36. Efficacy of calcium supplements on bone mass in postmenopausal women
37. Calcium intake and bone mass: A quantitative review of the evidence
38. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
39. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D1-4
40. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
41. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women
42. Nutrient effects: Discrepancy between data from controlled trials and observational studies
43. Vitamin D supplementation and fracture incidence in elderly people. A randomized placebo-controlled clinical trial
44. Correcting calcium nutritional deficiency prevents spine fractures in elderly women
45. Effect of calcium supplementation on bone loss in post-menopausal women
46. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
47. Calcium supplementation and bone loss in middle-aged women
48. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: A randomized placebo-controlled trial
49. Comparative evaluation of methods of collecting food intake data for cancer epidemiology
50. Indices of relative weight and obesity
51. The body mass index in clinical practice
52. Current methods and recent advances in the diagnosis of osteoporosis
53. Dietary fat and calcium intakes of menopausal women
54. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women
55. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical trial
56. Vitamin D3 and calcium to prevent hip fractures in elderly women
57. Effect of Vitamin D supplementation of wintertime and overall bone loss in healthy postmenopausal women
58. Calcium and vitamin D nutritional needs of elderly women
59. Postmenopausal breast cancer survivors at risk for osteoporosis: Physical activity, vigor, and vitality